The American Journal of Managed Care9 天
Venetoclax Shows Good Results Even in Short-Telomere Patients With CLL
New data suggest venetoclax may offset the negative prognostic impact of short telomeres in patients with chronic lymphocytic leukemia (CLL). A pair of studies examining the role of venetoclax ...
Business Wire1 个月
Delta-Fly Pharma Inc.: Update for Development Status of the Combination Study of DFP-10917 ...
has approved the tolerability of the first three patients enrolled in the Phase I/II clinical trial of DFP-10917 in combination with Venetoclax (VEN) (NCT06382168) conducted at five US clinical ...
The American Journal of Managed Care24 天
SPOTLIGHT: Shorter Duration of Venetoclax Is Possible for Some Patients With Newly ...
Tailoring the duration of venetoclax (Venclexta; AbbVie, Genentech) treatment may optimize the therapeutic efficacy of the treatment in patients with newly diagnosed acute myeloid leukemia (AML ...
Scoop14 天
Pharmac Consulting On Widening Access To Venetoclax, Azacitidine And Upadacitinib
The medicines and health conditions are: venetoclax (brand name Venclexta) in combination with azacitidine or cytarabine for a type of blood cancer called acute myeloid leukaemia azacitidine to be ...